Study at a glance
What happens when heart muscle cells lose vitamin D receptors?
Two studies used genetically changed mice to examine vitamin D receptors in heart muscle cells. These receptors are proteins that receive vitamin D signals. The researchers asked whether losing them changes heart structure or pumping. This is different from testing vitamin D supplements or studying a low vitamin D blood result in people.
What happened to mouse hearts in the 2011 study?
The 2011 study found larger heart muscle cells and thicker heart walls after receptor loss. It did not demonstrate worse pumping on the tests used or more scar tissue. Measured blood pressure was lower rather than higher. A separate experiment in newborn rat heart cells suggested a possible cell-growth mechanism, but did not prove that this mechanism explained the whole effect.
How did mouse hearts respond to stress in the 2024 study?
The 2024 study used different genetics and surgery that made the heart pump against greater pressure. It did not find the same abnormal pattern before this stress. Afterwards, mice lacking the receptors had worse ultrasound measures of pumping, but similar muscle-cell enlargement and measured scarring. Other tests of contraction and relaxation did not show the same difference. Gene-activity findings based on one heart section per group were exploratory, not proof of extra scar tissue.
Do these mouse findings show a treatment benefit in people?
Vitamin D receptor signals can matter in these mouse models, but the result depends on the experiment and what is measured. Heart enlargement, scarring and reduced pumping are separate findings. Small studies using different designs do not establish one rule for every setting. Neither study shows a treatment benefit in people or defines a vitamin D supplement dose or blood target.
Read the full article below ↓Vitamin D receptors in heart muscle may influence how the heart responds to stress, but mouse studies do not all show the same outcome. Chen and colleagues’ 2011 experiment found enlarged muscle after receptor deletion without a demonstrated decline in the assessed pumping function. A later experiment found a different balance between structure and function. For the detailed methods, results and comparison, read Vitamin D Receptors in Heart Muscle and Cardiac Remodelling: Full Study.
What the researchers tested
A cardiomyocyte is a heart muscle cell. Chen’s team used genetic engineering to remove functional vitamin D receptors from these cells in approximately six-month-old mice. The question was whether receptor loss within the muscle could affect cardiac growth, rather than whether supplements benefited people.
The main comparison used mice sharing a background in which one vitamin D receptor gene copy was already inactive throughout the body. The remaining targeted copy was deleted in the cardiomyocytes of the experimental group. The researchers examined baseline animals and animals receiving seven days of isoproterenol, a drug used experimentally to stimulate cardiac growth.
What the 2011 study found
Left ventricular weight relative to body weight averaged 2.69 mg/g in baseline controls and 3.16 mg/g in the receptor-deletion group. With isoproterenol, the corresponding values were 3.27 and 3.78 mg/g. The results table reports 8-12 mice per group. Microscopy showed larger muscle cells, and ultrasound showed thicker ventricular walls.
These were structural findings. The investigators did not find increased interstitial fibrosis, and they reported no significant genotype difference in the assessed systolic or diastolic function. Ejection fraction, the proportion of the filled chamber volume expelled in a beat, was similar. A larger heart muscle therefore should not be described as demonstrated pump failure in this experiment.
Calcium and parathyroid hormone measurements did not show the major disturbances found in whole-body receptor knockouts. Measured diastolic and mean arterial pressure were lower in the heart-cell knockout mice, making increased measured blood pressure an unlikely simple explanation for their enlargement.
A possible signalling mechanism
The enlarged hearts had increased modulatory calcineurin inhibitory protein 1 (MCIP1), a protein associated with a signalling pathway involving the calcineurin enzyme and gene-regulating NFAT proteins. In a separate experiment using newborn rat heart cells, active vitamin D partially reduced isoproterenol-induced MCIP1 RNA, protein and promoter activity.
The two findings make this pathway a plausible contributor. They do not establish that it is the only mechanism or prove that supplementing adult humans would reverse the changes. The cultured-cell experiment was not a treatment trial in the adult knockout mice.
Why the later study matters
In 2024, Zupcic and colleagues used a different genetic construction and four weeks of pressure overload caused by narrowing the aorta. Their male mice did not show the earlier study’s abnormal baseline phenotype. After pressure overload, both genotypes had similar muscle-cell enlargement and measured fibrosis, but the knockout animals had worse ultrasound measures of pumping. There were five mice in each pressure-overload group for those ultrasound comparisons.
Other measurements did not all separate the groups: catheter-based contraction and relaxation indices showed no corresponding genotype difference. An exploratory RNA-mapping analysis suggested stronger inflammatory and fibrosis-related signalling, but it compared only one heart section per genotype. Molecular signals associated with fibrosis were not proof of greater deposited scar tissue.
What this means for readers
The studies use different genetics and different stressors, so their results cannot be reduced to a single rule that receptor loss always enlarges the heart. They contribute to understanding vitamin D and heart physiology by separating local receptor biology, structural remodelling and measured function.
Neither study defines a supplement dose, a blood target or a demonstrated treatment benefit in people. Vitamin D status and vitamin D effect are different questions: removing a receptor is not equivalent to observing a low blood concentration. The appropriate conclusion is that cardiac receptor signalling deserves investigation within clearly specified models, while human treatment claims require human intervention evidence.
Scientific sources
Chen S, Law CS, Grigsby CL, Olsen K, Hong TT, Zhang Y, Yeghiazarians Y, Gardner DG. Cardiomyocyte-Specific Deletion of the Vitamin D Receptor Gene Results in Cardiac Hypertrophy. Circulation. 2011;124(17):1838-1847. DOI: 10.1161/CIRCULATIONAHA.111.032680. PMID: 21947295. The principal experiment; supplementary methods and echocardiography are part of this publication.
Zupcic A, Latic N, Oubounyt M, Ramesova A, Carmeliet G, Baumbach J, Elkjaer ML, Erben RG. Ablation of Vitamin D Signaling in Cardiomyocytes Leads to Functional Impairment and Stimulation of Pro-Inflammatory and Pro-Fibrotic Gene Regulatory Networks in a Left Ventricular Hypertrophy Model in Mice. International Journal of Molecular Sciences. 2024;25(11):5929. DOI: 10.3390/ijms25115929. PMID: 38892126. A separate mouse experiment used here to assess the consistency and limits of the earlier findings.
Related reading
Serum calcium and 25-hydroxyvitamin D in relation to longevity, cardiovascular disease and cancer: a Mendelian randomization study
Associations of serum calcium (S-Ca) and 25-hydroxyvitamin D (S-25(OH)D) concentrations with longevity, cardiovascular disease, and cancer are not clear.
Original paper ↗Read more →Vitamin D3 repletion versus placebo as adjunctive treatment of heart failure patient quality of life and hormonal indices: a randomized, double-blind, placebo-controlled trial
The objective of this study was to determine if vitamin D3 at a comparatively high dose would replete 25-hydroxyvitamin D (25(OH)D) stores, improve BNP, PTH, cardiopulmonary function, reduce inflammatory markers, and improve quality of life (QOL) in HF patients.
Original paper ↗Read more →Ablation of Vitamin D Signaling in Cardiomyocytes Leads to Functional Impairment and Stimulation of Pro-Inflammatory and Pro-Fibrotic Gene Regulatory Networks in a Left Ventricular Hypertrophy Model in Mice
This study aimed to further elucidate the role of vitamin D signaling in the development of left ventricular (LV) hypertrophy and dysfunction.
Original paper ↗Read more →Vitamin D Receptors in Heart Muscle and Cardiac Remodelling: Full Study
Examine mouse studies of vitamin D receptors in heart muscle, cardiac enlargement and pumping function, including conflicting findings and human limits.
Read more →Interactions between vitamin D receptor (VDR) gene and Interleukin-6 gene and environment factors on coronary heart disease risk in a Chinese Han population
Stratified analysis for gene: smoking interaction was investigated by logistic regression.
Original paper ↗Read more →Vitamin D Receptor Deficiency Does Not Affect Blood Pressure and Heart Function
Vitamin D is thought to play a role in blood pressure regulation, which in turn can influence cardiovascular risk.
Original paper ↗Read more →Inflammation and Vitamin D Receptor Polymorphism: Impact on All-Cause and Cardiovascular Mortality in Mexican Women on Dialysis
This study aimed to determine how these factors affect mortality.
Original paper ↗Read more →Inhibition of Stat3 signaling ameliorates atrophy of the soleus muscles in mice lacking the vitamin D receptor
To investigate the involvement of satellite cells (SCs) in atrophy in VDR−/− mice, we found that there was no significant deficit in SC numbers in VDR−/− muscles compared to the wild type.
Original paper ↗Read more →Comparative Analyses of the Safety Profiles of Vitamin D Receptor Agonists: A Pharmacovigilance Study Based on the EudraVigilance Database
This study aimed to analyze the safety profiles of VDR agonists using the EudraVigilance database, focusing on adverse drug reactions (ADRs) reported between 1 January 2004 and 23 June 2024.
Original paper ↗Read more →Correlation between Sirtuin 1 downregulation and reduced vitamin D receptor expression in patients with diabetic neuropathy
Fifty-one participants with T2D, who underwent neurological assessment for DN were recruited.
Original paper ↗Read more →Effect of Vitamin D Receptor Activators on Glomerular Filtration Rate: A Meta-Analysis and Systematic Review
We conducted a systematic review and meta-analysis of randomized clinical trials (RCTs) to evaluate the effect of VDRAs on kidney function and adverse events.
Original paper ↗Read more →Identification of Novel Non-secosteroidal Vitamin D Receptor Agonists with Potent Cardioprotective Effects and devoid of Hypercalcemia
Vitamin D regulates many biological processes, but its clinical utility is limited by its hypercalcemic effect.
Original paper ↗Read more →The role of vitamin D receptor and IL‐6 in COVID‐19
This study investigated the changes in vitamin D receptor (VDR) expression and interleukin 6 levels in patients with COVID‐19.
Original paper ↗Read more →Vitamin D Receptor Expression in Dogs
Thirty‐five dogs diagnosed with a chronic enteropathy (CE) and 24 control dogs were prospectively enrolled and duodenal biopsies were evaluated for VDR expression.
Original paper ↗Read more →Vitamin D receptor gene polymorphism predicts left ventricular hypertrophy in maintenance hemodialysis
The results showed that the risks of CVD included gender, dialysis time, heart rate, SBP, glycated hemoglobin, calcium, iPTH and CRP concentration.
Original paper ↗Read more →Abnormal pattern of vitamin D receptor-associated genes and lncRNAs in patients with bipolar disorder
With the purpose of exploring the role of vitamin D receptor (VDR) signaling in this disorder, we measured expression of selected mRNA coding genes and long non-coding RNAs (lncRNAs) in this pathway in patients versus normal subjects.
Original paper ↗Read more →MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma
Cholangiocarcinoma (CCA) is a devastating disease due to no effective treatments available.
Original paper ↗Read more →Effect of Calcitriol and Vitamin D Receptor Modulator 2 on Recovery of Injured Skeletal Muscle in Wistar Rats
Muscle injuries often result in functional limitations due to insufficient healing.
Original paper ↗Read more →Overexpression of the vitamin D receptor (VDR) induces skeletal muscle hypertrophy
Finally, human participants underwent 20 wks of resistance exercise training, with body composition and transcriptomic analysis.
Original paper ↗Read more →Relationship of vitamin D receptor gene polymorphism with sarcopenia and muscle traits based on propensity score matching
Vitamin D receptor (VDR) gene polymorphism is reported to be associated with muscle mass and muscle strength.
Original paper ↗Read more →The role of vitamin D in skeletal and cardiac muscle function
Myopathy is a feature of many inflammatory syndromes.
Original paper ↗Read more →Original sources
Cardiomyocyte-Specific Deletion of the Vitamin D Receptor Gene Results in Cardiac Hypertrophy
Published in Circulation (2011).
Publication details
Chen S, Law CS, Grigsby CL, Olsen K, Hong TT, Zhang Y, Yeghiazarians Y, Gardner DG. Cardiomyocyte-Specific Deletion of the Vitamin D Receptor Gene Results in Cardiac Hypertrophy. Circulation. 2011;124(17):1838-1847. DOI: 10.1161/CIRCULATIONAHA.111.032680. PMID: 21947295. The principal experiment; supplementary methods and echocardiography are part of this publication.
Ablation of Vitamin D Signaling in Cardiomyocytes Leads to Functional Impairment and Stimulation of Pro-Inflammatory and Pro-Fibrotic Gene Regulatory Networks in a Left Ventricular Hypertrophy Model in Mice
This study aimed to further elucidate the role of vitamin D signaling in the development of left ventricular (LV) hypertrophy and dysfunction.
Publication details
Zupcic A, Latic N, Oubounyt M, Ramesova A, Carmeliet G, Baumbach J, Elkjaer ML, Erben RG. Ablation of Vitamin D Signaling in Cardiomyocytes Leads to Functional Impairment and Stimulation of Pro-Inflammatory and Pro-Fibrotic Gene Regulatory Networks in a Left Ventricular Hypertrophy Model in Mice. International Journal of Molecular Sciences. 2024;25(11):5929. DOI: 10.3390/ijms25115929. PMID: 38892126. A separate mouse experiment used here to assess the consistency and limits of the earlier findings.